Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Moxifloxacin Hydrochloride prices in Germany, the highest-cost reporting region, rose 7.0% in H1 2026, climbing from USD 138.0/KG in Q1 to USD 147.7/KG by Q2 as recovering community-acquired pneumonia, complicated intra-abdominal infection, and ophthalmic infection treatment procurement and firmer fourth-generation fluoroquinolone synthesis intermediate costs reversed the H2 2025 API market softening. Globally, the average rose from USD 97.88/KG in Q1 to USD 104.74/KG in Q2, a 7.0% gain. For H2 2026, a global average of USD 105.80-116.60/KG is expected, with continued firming on Middle East supply disruptions and growing respiratory and intra-abdominal infection therapy sector demand globally.
Moxifloxacin Hydrochloride is a fourth-generation fluoroquinolone antibiotic produced by multi-step chemical synthesis from a substituted dichlorofluoroaniline precursor through Gould-Jacobs quinolone ring formation, introduction of the unique 8-methoxyl group at position 8 of the quinolone scaffold, and cyclopropylamine and 2,8-diazabicyclo[4.3.0]nonane side chain attachment steps to yield the active free base, converted to the stable monohydrochloride salt for pharmaceutical use. The 8-methoxy substitution and bicyclic amine side chain confer enhanced Gram-positive and anaerobic bacterial coverage compared to earlier fluoroquinolone generations, with improved activity against Streptococcus pneumoniae and atypical respiratory pathogens. The compound inhibits both DNA gyrase and topoisomerase IV with more balanced potency, reducing the emergence of target mutation resistance. The largest pull comes from community-acquired pneumonia and acute bacterial sinusitis treatment, where enhanced Gram-positive and atypical coverage supports prescribing in moderate-to-severe cases. Complicated intra-abdominal infection combination therapy, skin and soft tissue infection management, and ophthalmic antibacterial eye drop formulations for bacterial conjunctivitis add further demand. Synthesis intermediate costs, respiratory infection treatment volumes, and regional API production capacity all feed into the price.
The balance of supply and demand for Moxifloxacin Hydrochloride through H2 2026 leans moderately firm. Fluoroquinolone synthesis intermediate costs firmed from Middle East chemical supply disruptions. Community-acquired pneumonia treatment prescribing, intra-abdominal infection management, and ophthalmic antibacterial demand are growing with expanding respiratory disease burden and antibiotic access.
The main upside risk is synthesis intermediate cost increases alongside accelerating respiratory illness and CAP treatment demand. The main downside risk is continued Chinese and Indian API surplus and generic competition maintaining price pressure below forecast.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 105.80 - 116.60 | Synthesis cost firming and respiratory/intra-abdominal demand |
| United States | 113.40 - 124.20 | Steady CAP and intra-abdominal infection demand holds firm |
| China | 79.70 - 90.50 | Large API capacity keeps it the most affordable |
| Germany | 148.80 - 159.60 | High synthesis and energy costs keep it the most expensive |
| India | 108.20 - 119.00 | Growing respiratory and export demand holds a firm middle |
US Moxifloxacin Hydrochloride prices averaged USD 120.2/KG in Q2 2026, up 7.0% from USD 112.3/KG in Q1 2026. Firmer synthesis intermediate costs and recovering community-acquired pneumonia and intra-abdominal infection treatment procurement drove consistent buying through the quarter.
Why did the price of Moxifloxacin Hydrochloride change in Q2 2026 in the United States?
Firmer fourth-generation fluoroquinolone synthesis intermediate costs raised the API production floor. Community-acquired pneumonia, sinusitis, and intra-abdominal infection treatment procurement lifted buying. Ophthalmic eye drop and skin infection treatment demand provided additional buying support near USD 120.2/KG.
Chinese Moxifloxacin Hydrochloride prices averaged USD 83.7/KG in Q2 2026, up 7.0% from USD 78.2/KG in Q1 2026, the lowest among the tracked markets. Spring respiratory and intra-abdominal infection export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the floor despite domestic API capacity.
Why did the price of Moxifloxacin Hydrochloride change in Q2 2026 in China?
Spring respiratory and intra-abdominal infection treatment export and domestic procurement lifted buying. Firmer domestic fluoroquinolone synthesis intermediate costs raised the production floor. Domestic API capacity kept China the most affordable source.
German Moxifloxacin Hydrochloride prices averaged USD 147.7/KG in Q2 2026, up 7.0% from USD 138.0/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European API production economics. Recovering respiratory infection, intra-abdominal, and ophthalmic demand maintained buying.
Why did the price of Moxifloxacin Hydrochloride change in Q2 2026 in Germany?
Higher fluoroquinolone synthesis intermediate and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to synthesis substrate supply chains. Recovering community-acquired pneumonia, intra-abdominal, and ophthalmic infection procurement maintained buying near USD 147.7/KG.
Indian Moxifloxacin Hydrochloride prices averaged USD 113.5/KG in Q2 2026, up 7.0% from USD 106.1/KG in Q1 2026. Growing respiratory and intra-abdominal infection export and domestic demand supported buying. Firmer synthesis import costs raised the production floor.
Why did the price of Moxifloxacin Hydrochloride change in Q2 2026 in India?
Growing community-acquired pneumonia and intra-abdominal infection export and domestic procurement lifted buying. Firmer fluoroquinolone synthesis import costs raised the production floor. Ophthalmic eye drop export demand provided additional buying support near USD 113.5/KG.
US Moxifloxacin Hydrochloride prices averaged USD 112.3/KG in Q1 2026, recovering about 4.0% from the Q4 2025 softening trough. Recovering respiratory and intra-abdominal infection demand and firming synthesis costs held the market near USD 112.3/KG.
Why did the price of Moxifloxacin Hydrochloride change in Q1 2026 in the United States?
Recovering community-acquired pneumonia and intra-abdominal infection treatment procurement maintained buying. Firming fluoroquinolone synthesis intermediate costs raised the production floor. The market recovered to USD 112.3/KG from the H2 2025 API softening trough.
Chinese prices averaged USD 78.2/KG in Q1 2026, recovering about 4.0% from Q4 2025. Post-Lunar New Year respiratory and intra-abdominal restocking and firming synthesis costs held the market near USD 78.2/KG.
Why did the price of Moxifloxacin Hydrochloride change in Q1 2026 in China?
Post-Lunar New Year respiratory and intra-abdominal infection restocking lifted buying. Firming domestic synthesis intermediate costs raised the production floor. The market recovered to USD 78.2/KG from the H2 2025 API softening trough.
German prices averaged USD 138.0/KG in Q1 2026, recovering about 4.1% from Q4 2025. Recovering respiratory and intra-abdominal demand and firming synthesis and energy costs held the market near USD 138.0/KG.
Why did the price of Moxifloxacin Hydrochloride change in Q1 2026 in Germany?
Recovering community-acquired pneumonia and intra-abdominal infection procurement maintained buying. Firming synthesis intermediate and energy costs held the production floor. The market recovered to USD 138.0/KG from the H2 2025 API softening trough.
Indian prices averaged USD 106.1/KG in Q1 2026, recovering about 4.0% from Q4 2025. Growing respiratory and intra-abdominal demand and firming synthesis import costs held the market near USD 106.1/KG.
Why did the price of Moxifloxacin Hydrochloride change in Q1 2026 in India?
Growing community-acquired pneumonia and intra-abdominal infection export and domestic procurement maintained buying. Firming synthesis import costs raised the production floor. The market recovered to USD 106.1/KG from the H2 2025 API softening trough.
Global Moxifloxacin Hydrochloride prices declined through H2 2025 on API synthesis cost softening before recovering firmly through Q1 and Q2 2026. The average fell from USD 98.0/KG in Q2 2025 to USD 96.04/KG in Q3 and USD 94.12/KG in Q4, then recovered to USD 97.88/KG in Q1 2026 and USD 104.74/KG in Q2 2026, a net gain of about 6.9% over the window. Fluoroquinolone synthesis intermediate cost cycles and respiratory and intra-abdominal infection treatment demand drove the H2 2025 softening and H1 2026 recovery.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 104.74 | +7.0% | ↑ Rising |
| Q1 2026 | 97.88 | +4.0% | ↑ Rising |
| Q4 2025 | 94.12 | -2.0% | ↓ Falling |
| Q3 2025 | 96.04 | -2.0% | ↓ Falling |
| Q2 2025 | 98.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Moxifloxacin Hydrochloride prices declined through 2025 as API synthesis cost softening and adequate supply weighed on the market. The global average opened near USD 100.5/KG in Q1 2025 and closed at USD 94.12/KG in Q4, a full-year decline of about 6.3%. Synthesis intermediate cost softening and Chinese API supply adequacy maintained downward pressure before the H1 2026 recovery.
US prices fell from about USD 113.5/KG in Q1 2025 to USD 108.0/KG by Q4, a decline of 4.8%. Synthesis cost softening and adequate API supply maintained the downward trend through the year.
Chinese prices fell from roughly USD 79.0/KG in Q1 2025 to USD 75.2/KG by Q4, a decline of 4.8%. Domestic API capacity and competitive generic pricing maintained the lowest price level throughout.
German prices fell from about USD 139.5/KG in Q1 2025 to USD 132.6/KG by Q4, a decline of 4.9%. Synthesis intermediate cost softening and soft European respiratory infection demand maintained the decline through the year.
Indian prices fell from roughly USD 107.3/KG in Q1 2025 to USD 102.0/KG by Q4, a decline of 4.9%. Synthesis import cost softening and competitive export API pricing maintained downward pressure.
Expert Market Research: Your Source for Real-Time Moxifloxacin Hydrochloride Price Intelligence
Expert Market Research tracks Moxifloxacin Hydrochloride prices continuously across every major producing and consuming region. The team traces causation through fourth-generation fluoroquinolone synthesis intermediate economics, respiratory and intra-abdominal infection treatment procurement cycles, and regional API production capacity. Contact Expert Market Research today for Moxifloxacin Hydrochloride pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Community-acquired pneumonia and acute bacterial sinusitis treatment with enhanced Gram-positive and atypical pathogen coverage takes the largest share. Complicated intra-abdominal infection combination therapy, skin and soft tissue infection management, ophthalmic antibacterial eye drop formulations for bacterial conjunctivitis, and pelvic inflammatory disease treatment also consume significant volumes globally.
The Q2 2026 average was USD 120.2/KG in the United States, USD 83.7/KG in China, USD 147.7/KG in Germany, and USD 113.5/KG in India. Germany remains the highest-priced market.
The global average rose from USD 97.88/KG in Q1 to about USD 104.74/KG in Q2, a gain of around 7.0%. Recovering respiratory and intra-abdominal infection demand and firmer fluoroquinolone synthesis costs drove the H1 2026 recovery from the H2 2025 softening.
Fluoroquinolone synthesis intermediate cost softening reduced the API production floor. Soft global respiratory infection season and Chinese API supply adequacy maintained downward pressure before the H1 2026 recovery.
The global average is expected in the USD 105.80 to 116.60/KG range for H2 2026, with continued firming as synthesis intermediate costs stay elevated and respiratory and intra-abdominal infection treatment demand grows globally.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on respiratory and intra-abdominal infection demand, and China prices lowest on domestic API capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to fourth-generation fluoroquinolone synthesis intermediate costs, respiratory infection season intensity, and intra-abdominal infection management protocol adoption. Respiratory illness surveillance data and synthesis precursor prices are key signals.
China and India hold the largest moxifloxacin API production capacity. Any fluoroquinolone synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time respiratory and intra-abdominal infection formulation contracts around synthesis cost cycles, build cover when fluoroquinolone intermediate signals tighten, and monitor respiratory illness surveillance as the primary demand signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.